These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 11051122)

  • 41. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
    Lerche H; Daniluk J; Lotay N; DeRossett S; Edwards S; Brandt C
    Seizure; 2015 Aug; 30():93-100. PubMed ID: 26216692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy.
    Tanaka S; Tanaka T
    Epileptic Disord; 2013 Jun; 15(2):132-41. PubMed ID: 23774199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seizure-free days observed in randomized placebo-controlled add-on trials with levetiracetam in partial epilepsy.
    Leppik I; Morrell M; Godfroid P; Arrigo C
    Epilepsia; 2003 Oct; 44(10):1350-2. PubMed ID: 14510829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group.
    Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E
    Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.
    Baulac M; Byrnes W; Williams P; Borghs S; Webster E; De Backer M; Dedeken P
    Acta Neurol Scand; 2017 Apr; 135(4):434-441. PubMed ID: 27714769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group.
    Epilepsia; 1999 Dec; 40(12):1767-74. PubMed ID: 10612342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.
    French JA; Abou-Khalil BW; Leroy RF; Yacubian EM; Shin P; Hall S; Mansbach H; Nohria V;
    Neurology; 2011 May; 76(18):1555-63. PubMed ID: 21451152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel.
    Montouris G; Yang H; Williams B; Zhou S; Laurenza A; Fain R
    Epilepsy Res; 2015 Aug; 114():131-40. PubMed ID: 26088896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of levetiracetam and oxcarbazepine monotherapy among Korean patients with newly diagnosed focal epilepsy: A long-term, randomized, open-label trial.
    Kim JH; Lee SK; Loesch C; Namgoong K; Lee HW; Hong SB;
    Epilepsia; 2017 Apr; 58(4):e70-e74. PubMed ID: 28395124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison.
    Zhang L; Li S; Li H; Zou X
    Seizure; 2016 Jul; 39():28-33. PubMed ID: 27236448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levetiracetam monotherapy for elderly patients with epilepsy.
    Alsaadi TM; Koopmans S; Apperson M; Farias S
    Seizure; 2004 Jan; 13(1):58-60. PubMed ID: 14741184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy.
    Berkovic SF; Knowlton RC; Leroy RF; Schiemann J; Falter U;
    Neurology; 2007 Oct; 69(18):1751-60. PubMed ID: 17625106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy.
    Ben-Menachem E; Gilland E
    Seizure; 2003 Apr; 12(3):131-5. PubMed ID: 12651076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
    French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
    Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of the initial efficacy of levetiracetam in patients with refractory epilepsy.
    Lee GH; Kim BM; Kang JK; Lee SA
    Seizure; 2013 Apr; 22(3):185-8. PubMed ID: 23280273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques.
    Richy FF; Banerjee S; Brabant Y; Helmers S
    Epilepsy Behav; 2009 Oct; 16(2):240-5. PubMed ID: 19699156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.
    Ben-Menachem E; Mameniškienė R; Quarato PP; Klein P; Gamage J; Schiemann J; Johnson ME; Whitesides J; McDonough B; Eckhardt K
    Neurology; 2016 Jul; 87(3):314-23. PubMed ID: 27335114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
    Baulac M; Brodie MJ; Elger CE; Krakow K; Stockis A; Meyvisch P; Falter U
    Epilepsia; 2007 Mar; 48(3):589-92. PubMed ID: 17326794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study.
    Alsaadi TM; Shatzel A; Marquez AV; Jorgensen J; Farias S
    Seizure; 2005 Mar; 14(2):139-42. PubMed ID: 15694569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.